Evidence map›Paper›PMID 35587292›Full record

ReviewPlanta2022

Genome editing and beyond: what does it mean for the future of plant breeding?

Tien Van Vu, Swati Das, Goetz Hensel, Jae-Yean Kim

Abstract readReview
In one paragraph

Review in Planta, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. CRISPR/Cas9 Technology and Its Utility for Crop Improvement.International journal of molecular sciences · 2022
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tien Van VuDivision of Applied Life Science (BK21 Four Program), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 660-701, Republic of Korea.
Swati DasDivision of Applied Life Science (BK21 Four Program), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 660-701, Republic of Korea.
Goetz HenselCentre for Plant Genome Engineering, Institute of Plant Biochemistry, Heinrich-Heine-University, Universitätsstraße 1, 40225, Düsseldorf, Germany. goetz.hensel@hhu.de.ORCID http://orcid.org/0000-0002-5539-3097
Jae-Yean KimDivision of Applied Life Science (BK21 Four Program), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 660-701, Republic of Korea. kimjy@gnu.ac.kr.ORCID http://orcid.org/0000-0002-1180-6232

Funding

Czech Science Foundation CZ.02.1.01./0.0/0.0/16_019/0000827Czech Science Foundation SPP 813103381Deutsche Forschungsgemeinschaft 426557363Deutsche Forschungsgemeinschaft 458717903Deutsche Forschungsgemeinschaft Germany's Excellence Strategy - EXC-2048/1 - project ID 390686111European Regional Development Fund ZS/2018/06/93171National Research Foundation of Korea 2020M3A9I4038352National Research Foundation of Korea 2020R1A6A1A03044344National Research Foundation of Korea 2020R1I1A1A01072130
6 · The paper itself

Abstract

MAIN

conclusionGenome editing offers revolutionized solutions for plant breeding to sustain food production to feed the world by 2050. Therefore, genome-edited products are increasingly recognized via more relaxed legislation and community adoption. The world population and food production are disproportionally growing in a manner that would have never matched each other under the current agricultural practices. The emerging crisis is more evident with the subtle changes in climate and the running-off of natural genetic resources that could be easily used in breeding in conventional ways. Under these circumstances, affordable CRISPR-Cas-based gene-editing technologies have brought hope and charged the old plant breeding machine with the most energetic and powerful fuel to address the challenges involved in feeding the world. What makes CRISPR-Cas the most powerful gene-editing technology? What are the differences between it and the other genetic engineering/breeding techniques? Would its products be labeled as "conventional" or "GMO"? There are so many questions to be answered, or that cannot be answered within the limitations of our current understanding. Therefore, we would like to discuss and answer some of the mentioned questions regarding recent progress in technology development. We hope this review will offer another view on the role of CRISPR-Cas technology in future of plant breeding for food production and beyond.

Indexed as

Gene EditingPlant BreedingCRISPR-Cas SystemsGenome, PlantPlants, Genetically ModifiedBiotechnology regulationCRISPR-CasCrop breedingGenome engineeringNew plant breeding techniques

Identifiers

PMID35587292
PMCPMC9120101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.